RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

This study tests an experimental RSV vaccine in Chinese adults aged 18 to 59 who have a higher risk of getting sick from RSV. The goal is to see if the vaccine produces a strong immune response in this group, similar to what was seen in older adults. About 750 participants will r…

This study looks at how well an RSV vaccine works and how safe it is in adults aged 18 and older who have had a lung or kidney transplant. Researchers will check if the immune response from a previous dose lasts and what happens when participants get another dose. The goal is to …

This study tests a new nasal spray vaccine (BLB-201) to prevent RSV, a common virus that can cause serious breathing problems in babies and young children. About 137 infants and children aged 8 months to 5 years will receive either the vaccine or a placebo. The goal is to see if …

This study tests an experimental antiviral drug called S-337395 in adults with RSV who are at high risk for severe illness but are not hospitalized. The goal is to see if the drug can reduce the amount of virus in the nose and throat faster than a placebo. About 192 participants …

This study tests whether the antibiotic azithromycin can help children with severe RSV infection who need breathing support in the ICU. Researchers want to see if it shortens hospital stays and reduces time on oxygen. About 370 children will take part, receiving either azithromyc…

This study looks at how common RSV (a respiratory virus) is in adults aged 60 and older who are hospitalized in Vietnam for breathing problems or worsening heart/lung conditions. Researchers will test samples from the nose or throat to confirm RSV and track its severity. The goal…